The company expects to share safety and efficacy results from the RAMP-205 expansion cohort in first-line advanced pancreatic cancer and initial results from the Phase I/IIa trial evaluating VS-7375 ...

Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 ...

Eli Lilly has shared positive results from a Phase II clinical trial (NCT06230523) evaluating eloralintide, an investigational once-weekly, selective amylin receptor, in adults with obesity or ...

Every year, millions of dollars are lost to delays and inefficiencies in utilization management, making it one of the most daunting obstacles impeding timely, a ...

Get the latest on MindMed’s Q3 2025 earnings: clinical trial milestones, financial strength, and pivotal Phase III data readouts expected in 2026.

Despite being one of the most data-rich industries in the world, healthcare data remains among the most siloed.

Research on TissueCypher by Horvath et al. honored with a Presidential Poster Award from the ACG Abstract Selection Committee, a distinction awarded to only 5-7% of abstracts for research deemed high ...

The NHS 10 Year Health Plan calls for a strategic shift to support people to live longer healthier and more independent lives ...

Is the health care system financially sustainable? When the HFMA asked industry experts, the answer was a resounding "no." ...

Q3 2025 Management View CEO Robert I. Blum described the quarter as “highly productive and defining,” emphasizing “significant progress across the company's priority objectives” as Cytokinetics ...

When equipped with real-time data and integrated into the care team, pharmacists and pharmacy benefit managers can proactively identify health risks, support care coordination, and close medication ...

Q3 2025 Management View CEO C. Mills emphasized Elutia's mission of "humanizing medicine so that patients can thrive without compromise," spotlighting the company's strategic focus on breast ...